Latest Breaking News On - Neurosciences stock down - Page 1 : comparemela.com

Minerva Neurosciences (NASDAQ:NERV) Raised to Hold at StockNews com

Minerva Neurosciences (NASDAQ:NERV) Raised to Hold at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Minerva neurosciencesMinerva neurosciences company profileMinerva neurosciences incFree reportNeurosciences stock downGet free reportNew drug applicationMinerva neurosciences daily

HC Wainwright Comments on Minerva Neurosciences, Inc s FY2028 Earnings (NASDAQ:NERV)

Minerva Neurosciences, Inc. (NASDAQ:NERV – Free Report) – Stock analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for Minerva Neurosciences in a research note issued on Friday, February 23rd. HC Wainwright analyst D. Tsao anticipates that the biopharmaceutical company will post earnings per share of $0.90 for the year. HC Wainwright […]

Minerva neurosciencesGeode capital managementMinerva neurosciences incNorthern trust corpJpmorgan chase coRenaissance technologiesFree reportMinerva neuroscienceNeurosciences stock downGet free reportCapital managementNew drug applicationMinerva neurosciences dailyNasdaq nervEarnings estimatesHc wainwright

Minerva Neurosciences (NASDAQ:NERV) Upgraded to Hold by StockNews com

StockNews.com upgraded shares of Minerva Neurosciences (NASDAQ:NERV – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, HC Wainwright upped their price objective on shares of Minerva Neurosciences from $8.00 to $11.00 and gave the company a neutral rating in a report on Wednesday, August 2nd. […]

Minerva neurosciencesMinerva neurosciences incRenaissance technologiesBlackrock incGeode capital managementJpmorgan chase coVirtu financialFree reportNeurosciences stock downGet free reportCapital managementNew drug applicationMinerva neurosciences dailyNasdaq nervStocknews com

Minerva Neurosciences, Inc (NASDAQ:NERV) Short Interest Down 20 3% in September

Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) saw a large decrease in short interest during the month of September. As of September 30th, there was short interest totalling 59,000 shares, a decrease of 20.3% from the September 15th total of 74,000 shares. Based on an average trading volume of 45,200 shares, the days-to-cover ratio […]

Minerva neurosciencesMinerva neurosciences incVirtu financialRenaissance technologiesMinerva neurosciences company profileBlackrock incGeode capital managementGet free reportNeurosciences stock downCapital managementNew drug applicationMinerva neurosciences dailyNasdaq nerv

Minerva Neurosciences (NASDAQ:NERV) Research Coverage Started at StockNews com

StockNews.com initiated coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Rating) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a neutral rating and set a $8.00 price objective on shares of Minerva Neurosciences in a report on Thursday, […]

Minerva neurosciencesRemy luthringerSecurities exchange commissionBlackrock incRenaissance technologiesMinerva neurosciences incGet ratingNeurosciences stock downPresident geoff raceExchange commissionNew drug applicationMinerva neurosciences dailyNasdaq nervInitiated coverageStocknews com